u/mcornack

"Aurora disputed Curaleaf's assertion that it refused to engage, stating that its lead independent director corresponded with Curaleaf's CEO as recently as July 24, 2026, indicating Aurora was focused on executing its existing business plan while not discouraging further dialogue.

The Aurora board said no decision has been made regarding the proposal and that there is no assurance any transaction will result. The company said shareholders do not need to take any action at this time"

This creates a global powerhouse!

On Monday's Cultivated Live, CEO Miguel Martin walks through Aurora's fiscal 2026 results and reveals a company executing a major strategic pivot. Approximately 58% of revenue came from international markets, driven by double-digit growth in Europe. The company completed an acquisition of Safari Flower Company in April, an established EU-GMP manufacturer, adding critical capacity to serve growing international markets.

Speaker:

• Andreas Dotterweich, SVP Europe, Aurora Europe

Bullet points:

• Aurora’s approach to world-class cannabis genetics and why differentiated genetics are critical to long-term success in the European market.
• How advanced cultivation capabilities, including domestic European production, support consistent quality, scalability, and patient trust.
• The role of operational excellence and product innovation in positioning Aurora as a global leader in medical cannabis delivery and European market acceleration.